Gainers
Statera BioPharma (NASDAQ:STAB) shares increased by 33.1% to $0.2 during Friday's pre-market session. The company's market cap stands at $10.4 million.
Workforce reductions of ~60% and implementation of a robust cost reduction plan are expected to extend the Company's cash runway into Q2 CY2024
The Company plans to maximize shareholder value by